Onxeo SA (C4X) is traded on Frankfurt Stock Exchange in Germany. and employs 22 people. The company currently falls under 'Micro-Cap
' category with current market capitalization of 54.73 M. Onxeo SA has 0 outstanding shares.
BIOALLIANCE PHARM has accumulated about 27.65 M in cash with (18.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55.
Check Onxeo SA Probability Of Bankruptcy